![Kooi June Lim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kooi June Lim
Profile
Kooi June Lim is currently working as a Director at Shanghai Jinghua Medical Management Co. Ltd. Prior to this, she served as a Non-Executive Director at ADICON Holdings Ltd. from 2020 to 2024.
She also worked as an Assistant Manager at Deloitte LLP from 2002 to 2004 and as a Senior Auditor at Citibank NA from 2004 to 2005.
Ms. Lim graduated from Nottingham University in 2000.
Kooi June Lim active positions
| Companies | Position | Start |
|---|---|---|
Shanghai Jinghua Medical Management Co. Ltd.
 Shanghai Jinghua Medical Management Co. Ltd. Develops vaccines based on its platform technologies, including recombinant protein and antigen expression systems in yeast | Director/Board Member | 01/09/2020 |
Former positions of Kooi June Lim
| Companies | Position | End |
|---|---|---|
| ADICON HOLDINGS LIMITED | Director/Board Member | 30/05/2024 |
Citibank NA /China Branch/ | Comptroller/Controller/Auditor | 01/05/2005 |
Deloitte LLP
 Deloitte LLP Provides audit, consulting, financial advisory, risk management and tax services | Corporate Officer/Principal | 01/04/2004 |
Training of Kooi June Lim
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Deloitte LLP
Deloitte LLP Provides audit, consulting, financial advisory, risk management and tax services | |
Citibank NA /China Branch/ | |
ADICON Holdings Ltd.
 ADICON Holdings Ltd. Operates as a holding company whose subsidiaries provides medical testing services and trading of related equipment | |
Nottingham University of /Uk/
 Nottingham University of /Uk/ Functions as a College/University | |
Shanghai Jinghua Medical Management Co. Ltd.
Shanghai Jinghua Medical Management Co. Ltd. Develops vaccines based on its platform technologies, including recombinant protein and antigen expression systems in yeast |
- Stock Market
- Insiders
- Kooi June Lim
